Stockreport

CRISPR Therapeutics (CRSP) Reports $116M FY25 Revenue Driven by CASGEVY Growth [Yahoo! Finance]

CRISPR Therapeutics AG - Common Shares  (CRSP) 
Last crispr therapeutics ag - common shares earnings: 8/7 05:01 pm Check Earnings Report
US:NASDAQ Investor Relations: nasdaq.com/symbol/crsp/real-time
PDF CRISPR Therapeutics (NASDAQ: CRSP ) is one of the best stocks for 20 years . On February 12, CRISPR Therapeutics announced its financial results for 2025, highlighting [Read more]